Spyre Therapeutics, Inc.

NASDAQ (USD): Spyre Therapeutics, Inc. (SYRE)

Last Price

31.93

Today's Change

-1.045 (3.16%)

Day's Change

31.74 - 33.47

Trading Volume

95,481

Financial

Reported Currency in USD
Show?
Last 10 FY Result (Thousand)
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 886 2,329 18,739 0 0 3,888 5,205 4,628 -21.02%
PBT -338,816 -83,951 -65,660 -80,893 -78,254 -44,348 -27,236 -21,698 48.06%
Tax -26 -136 141 -593 0 0 0 0 -
NP -338,790 -83,815 -65,801 -80,893 -78,254 -44,348 -27,236 -21,698 48.05%
Tax Rate - - - - - - - - -
Total Cost 339,676 86,144 84,540 80,893 78,254 48,236 32,441 26,326 44.08%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -38,238.15 -3,598.75 -351.14 0.00 0.00 -1,140.64 -523.27 -468.84 87.48%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.40 -1.70%
EPS Diluted -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.40 -1.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ & YoY figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment